MedTrace Logo

Ergospirometry in Paroxysmal Atrial Fibrillation Prognosis

NCT05246423 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-02-18

No results posted yet for this study

Summary

An observational, prospective, cohort study aiming to assess the potential predictive role of cardiopulmonary exercise testing in the prognosis of paroxysmal atrial fibrillation, in combination with echocardiographic indices and plasma biomarker values.

Conditions

Interventions

DIAGNOSTIC_TEST

Observation group

Patients with paroxysmal atrial fibrillation undergo cardiopulmonary exercise testing, echocardiography, 24-hour ambulatory electrocardiographic monitoring and plasma biomarkers' measurement

Sponsors & Collaborators

  • General Hospital Of Thessaloniki Ippokratio

    collaborator OTHER

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Aristi C. Boulmpou, MSc · Aristotle University of Thessaloniki, Greece

  • Christodoulos E. Papadopoulos, PhD · Aristotle University of Thessaloniki, Greece

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-10
Primary Completion
2024-12-10
Completion
2024-12-10

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05246423 on ClinicalTrials.gov